about
Why are women predisposed to autoimmune rheumatic diseases?Role of plasmacytoid dendritic cells for aberrant class II expression in exocrine glands from estrogen-deficient mice of healthy backgroundThe role of hormones in the pathogenesis of psoriasis vulgarisIncreased plasma/serum levels of prolactin in systemic lupus erythematosus: a systematic review and meta-analysis.The role of the prolactin/vasoinhibin axis in rheumatoid arthritis: an integrative overview.Evaluation of prolactin levels in patients with newly diagnosed pemphigus vulgaris and its correlation with pemphigus disease area index.Minireview: Extrapituitary prolactin: an update on the distribution, regulation, and functions.Increased levels of prolactin receptor expression correlate with the early onset of lupus symptoms and increased numbers of transitional-1 B cells after prolactin treatmentAcute onset polymyositis after prolactinoma extirpation.Prolactin may not play a role in primary antiphospholipid (Hughes') syndromeIncreased plasma/serum levels of prolactin in multiple sclerosis: a meta-analysis.Function of Treg Cells Decreased in Patients With Systemic Lupus Erythematosus Due To the Effect of ProlactinKlinefelter's syndrome (47,XXY) is in excess among men with Sjögren's syndromeProlactin promotes cartilage survival and attenuates inflammation in inflammatory arthritis.Secondary effects of antipsychotics: women at greater risk than men.Postpartum Granulomatous Hypophysitis: A Case Study, Review of the Literature, and Discussion of Pathogenesis.A retrospective study on IVF outcome in euthyroid patients with anti-thyroid antibodies: effects of levothyroxine, acetyl-salicylic acid and prednisolone adjuvant treatments.The prolactin receptor is expressed in rheumatoid arthritis and psoriatic arthritis synovial tissue and contributes to macrophage activation.Do serum prolactin levels correlate with antibodies against desmoglein in pemphigus vulgaris?Serum Prolactin Levels in Multiple Sclerosis, Neuromyelitis Optica, and Clinically Isolated Syndrome Patients.Schizophrenia: women bear a disproportionate toll of antipsychotic side effects.Immunological differences in women compared with men: overview and contributing factors.Adrenergic and dopaminergic modulation of immunity in multiple sclerosis: teaching old drugs new tricks?Concomitant myasthenia gravis and macroprolactinoma: the immunomodulatory role of prolactin and its potential therapeutic use.Endocrine autoimmune diseases and female infertility.Oral contraceptives, breastfeeding and the risk of developing rheumatoid arthritis: results from the Swedish EIRA study.Involvement of miR-106b in tumorigenic actions of both prolactin and estradiolVitamin D and autoimmunity.Evaluating serum prolactin and serum dehydroepiandrosterone sulfate levels in patients with pemphigus.Increased serum level of prolactin is related to autoantibody production in systemic lupus erythematosus.Prolactin and natural killer cells: evaluating the neuroendocrine-immune axis in women with primary infertility and recurrent spontaneous abortion.Influence of female hormonal factors, in relation to autoantibodies and genetic markers, on the development of rheumatoid arthritis in northern Sweden: a case-control study.The prolactin receptor: Diverse and emerging roles in pathophysiology.Prolactin levels are associated with a pro-inflammatory body mass distribution among women with systemic lupus erythematosus.Ovulation, a sign of health.High prolactin levels are independently associated with damage accrual in systemic lupus erythematosus patients.Prolactin and Autoimmunity.Interactions Between the Neuroendocrine System and T Lymphocytes in Diabetes.
P2860
Q21195367-1E716BA2-2D03-4F02-A5A4-1EFED6C5065EQ24273412-CD98536F-6D52-4157-B5EA-323BA58FD657Q26752733-D8EAD8F4-5F9D-4413-8CDB-9736C8B5E783Q30245103-C1E56DB6-4B0C-415B-861F-CE8977AAFE50Q30251689-1F5D799C-EAA3-4E6F-BC34-EC91F6104EA7Q33623717-3E09EE95-5F02-44F9-B8EF-8DF3F249A3DBQ33632082-74A2593D-4DD8-4228-9F8E-E6B1FCDA5CA1Q34190173-68817B50-B9DE-4432-9324-6FE9A373EE67Q34560427-4E47A42C-7365-4C5F-9FFC-3E5B543769D5Q34983272-989B9404-65F2-4E28-845E-096D6BF4285AQ36259406-394F046C-1663-4C9C-84B1-FCA5C5E49B3CQ36566751-BD23908C-7DDC-4022-954E-07D0B059664CQ37083442-207D8F1C-5D20-4832-BC59-B5D9FF4919DDQ37123943-FD61B3D3-9DDB-4497-BAD5-3545D0F66AFBQ37133664-6CC3D66E-10CC-4A3E-B7FD-8701306F8836Q37236080-BA84C052-E2DA-4211-B2E0-864AEA6CEAB9Q37458802-77A180B4-1EBB-4274-93E9-C2C786478FCDQ37484879-4E96D27F-0D56-459A-8750-5D0AD2C9547BQ37572250-FD0F33E9-F95B-418F-9C7D-6DC988A8751FQ37703766-111D6DE4-33BD-4F4D-BB11-335316FF0BEFQ37887304-C19675E1-0441-47FB-AAC4-634987763E98Q37900347-44C95722-0A04-49F3-941B-E17FBC0A948EQ38052870-00934FD0-A097-4E86-A791-6D8135E42C7CQ38113168-D0E41AB5-83C0-4272-A8B3-2698840295C1Q38159892-F4CEEB2C-A5D9-4196-819E-CEEF666CAB14Q38619263-36274874-94C5-4AA9-A613-2D3E0BF344F2Q38706936-FDA52CBE-E4D0-4623-B59B-9B803F8517E2Q38837175-4385B66B-1198-4501-8824-CD157882F2F1Q39972420-DEDC7687-8F9D-433B-8B4A-96F558956C39Q40200822-23FF465C-01BB-4DD9-89C9-70A818EF870DQ42467663-2FF22DD1-FD62-47FD-A434-6BF7E386B08CQ43013066-59957AE8-AB9B-4634-9A12-78E0A19391EAQ47137743-4FBAFC2B-4AA4-4947-8748-B91F182B949CQ47945429-0FC81C17-97FE-44D5-9FC4-B84E2FD94A75Q48097147-E8A32B5E-02A5-405B-BF62-798BE28FE313Q51147441-75A1D862-99C1-44EC-9C7C-9D96AFC6480BQ52372437-3944E7A4-9C7E-498A-85E3-A2608C797A35Q55337327-4FE35AB8-DCED-474A-BB71-E8D64479C6BA
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Hyperprolactinemia and autoimmune diseases.
@en
type
label
Hyperprolactinemia and autoimmune diseases.
@en
prefLabel
Hyperprolactinemia and autoimmune diseases.
@en
P1433
P1476
Hyperprolactinemia and autoimmune diseases.
@en
P304
P356
10.1016/J.AUTREV.2006.10.005
P577
2006-12-01T00:00:00Z